Abnormal increase in FGF21 levels has been consider as a signal of endothelial cell injury (52) as reported in the diseases including obesity, dyslipidemia, metabolic syndrome, hypertension, CAD, DM, and nonalcoholic fatty liver (53–55). Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.